These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 7968239)
1. Passage of human amyloid beta-protein 1-40 across the murine blood-brain barrier. Maness LM; Banks WA; Podlisny MB; Selkoe DJ; Kastin AJ Life Sci; 1994; 55(21):1643-50. PubMed ID: 7968239 [TBL] [Abstract][Full Text] [Related]
2. Lack of saturable transport across the blood-brain barrier in either direction for beta-amyloid1-28 (Alzheimer's disease protein). Banks WA; Kastin AJ; Barrera CM; Maness LM Brain Res Bull; 1991 Dec; 27(6):819-23. PubMed ID: 1786560 [TBL] [Abstract][Full Text] [Related]
3. Aluminum-sensitive degradation of amyloid beta-protein 1-40 by murine and human intracellular enzymes. Banks WA; Maness LM; Banks MF; Kastin AJ Neurotoxicol Teratol; 1996; 18(6):671-7. PubMed ID: 8947944 [TBL] [Abstract][Full Text] [Related]
5. The choroid plexus removes beta-amyloid from brain cerebrospinal fluid. Crossgrove JS; Li GJ; Zheng W Exp Biol Med (Maywood); 2005 Nov; 230(10):771-6. PubMed ID: 16246905 [TBL] [Abstract][Full Text] [Related]
6. Antibodies to beta-amyloid decrease the blood-to-brain transfer of beta-amyloid peptide. Pan W; Solomon B; Maness LM; Kastin AJ Exp Biol Med (Maywood); 2002 Sep; 227(8):609-15. PubMed ID: 12192102 [TBL] [Abstract][Full Text] [Related]
7. Vector-mediated delivery of 125I-labeled beta-amyloid peptide A beta 1-40 through the blood-brain barrier and binding to Alzheimer disease amyloid of the A beta 1-40/vector complex. Saito Y; Buciak J; Yang J; Pardridge WM Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10227-31. PubMed ID: 7479757 [TBL] [Abstract][Full Text] [Related]
8. Differential transport of a secretin analog across the blood-brain and blood-cerebrospinal fluid barriers of the mouse. Banks WA; Goulet M; Rusche JR; Niehoff ML; Boismenu R J Pharmacol Exp Ther; 2002 Sep; 302(3):1062-9. PubMed ID: 12183664 [TBL] [Abstract][Full Text] [Related]
9. Changing the chemokine gradient: CINC1 crosses the blood-brain barrier. Pan W; Kastin AJ J Neuroimmunol; 2001 Apr; 115(1-2):64-70. PubMed ID: 11282155 [TBL] [Abstract][Full Text] [Related]
10. Passage of vasoactive intestinal peptide across the blood-brain barrier. Dogrukol-Ak D; Banks WA; Tuncel N; Tuncel M Peptides; 2003 Mar; 24(3):437-44. PubMed ID: 12732342 [TBL] [Abstract][Full Text] [Related]
11. Granulocyte-macrophage colony-stimulating factor crosses the blood--brain and blood--spinal cord barriers. McLay RN; Kimura M; Banks WA; Kastin AJ Brain; 1997 Nov; 120 ( Pt 11)():2083-91. PubMed ID: 9397023 [TBL] [Abstract][Full Text] [Related]
12. Evidence of blood-brain barrier permeability/leakage for circulating human Alzheimer's beta-amyloid-(1-42)-peptide. Pluta R; Barcikowska M; Januszewski S; Misicka A; Lipkowski AW Neuroreport; 1996 May; 7(7):1261-5. PubMed ID: 8817545 [TBL] [Abstract][Full Text] [Related]
14. Passage of amyloid beta protein antibody across the blood-brain barrier in a mouse model of Alzheimer's disease. Banks WA; Terrell B; Farr SA; Robinson SM; Nonaka N; Morley JE Peptides; 2002 Dec; 23(12):2223-6. PubMed ID: 12535702 [TBL] [Abstract][Full Text] [Related]
15. Amyloid-β concentration and structure influences the transport and immunomodulatory effects of IVIG. Wuest DM; Lee KH J Neurochem; 2014 Jul; 130(1):136-44. PubMed ID: 24517534 [TBL] [Abstract][Full Text] [Related]
16. Human blood-brain barrier receptors for Alzheimer's amyloid-beta 1- 40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer. Mackic JB; Stins M; McComb JG; Calero M; Ghiso J; Kim KS; Yan SD; Stern D; Schmidt AM; Frangione B; Zlokovic BV J Clin Invest; 1998 Aug; 102(4):734-43. PubMed ID: 9710442 [TBL] [Abstract][Full Text] [Related]
17. Interleukin-1 alpha in blood has direct access to cortical brain cells. Banks WA; Kastin AJ; Gutierrez EG Neurosci Lett; 1993 Nov; 163(1):41-4. PubMed ID: 8295729 [TBL] [Abstract][Full Text] [Related]
18. Effects of transthyretin on thyroxine and β-amyloid removal from cerebrospinal fluid in mice. Chen R; Chen CP; Preston JE Clin Exp Pharmacol Physiol; 2016 Sep; 43(9):844-50. PubMed ID: 27220110 [TBL] [Abstract][Full Text] [Related]
19. Modulation of Amyloid-β1-40 Transport by ApoA1 and ApoJ Across an in vitro Model of the Blood-Brain Barrier. Merino-Zamorano C; Fernández-de Retana S; Montañola A; Batlle A; Saint-Pol J; Mysiorek C; Gosselet F; Montaner J; Hernández-Guillamon M J Alzheimers Dis; 2016 May; 53(2):677-91. PubMed ID: 27232214 [TBL] [Abstract][Full Text] [Related]
20. Isoform-specific effects of apolipoproteins E2, E3, and E4 on cerebral capillary sequestration and blood-brain barrier transport of circulating Alzheimer's amyloid beta. Martel CL; Mackic JB; Matsubara E; Governale S; Miguel C; Miao W; McComb JG; Frangione B; Ghiso J; Zlokovic BV J Neurochem; 1997 Nov; 69(5):1995-2004. PubMed ID: 9349544 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]